Magnus Nakrem Lyngbakken

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Steven H J Hageman, Lisa Pennells, Francisco Ojeda et al. · European Heart Journal · 2021 · 1.5K citations · Full text

Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium

Fabian J. Brunner, Christoph Waldeyer, Francisco Ojeda et al. · The Lancet · 2019 · 274 citations · Full text

Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study)

Fjola D. Sigurdardottir, Magnus Nakrem Lyngbakken, Oddgeir L. Holmen et al. · The American Journal of Cardiology · 2018 · 88 citations · Full text

Prognostic Evaluation, Cardiovascular Epidemiology, Cardiovascular Disease +9

Prognostic Value of Cardiovascular Biomarkers in the Population

Raphael Twerenbold, Jessica Weimann, Christie M. Ballantyne et al. · JAMA · 2024 · 87 citations · Full text

A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics

Magnus Nakrem Lyngbakken, Jan-Erik Berdal, Arne Nørgaard Eskesen et al. · Nature Communications · 2020 · 79 citations · Full text